Benchmark Evidence Against Venture DNA and Criteria
The founder cross-references the filtered customer evidence against the core assumptions recorded in the venture DNA, such as urgency, willingness to pay, and problem severity. They rigorously check whether the data supports the precise hypotheses formulated during stage planning. Any deviation between target criteria and actual evidence is rigorously documented.
Completing this action measures current market proof directly against the core hypotheses and strategic criteria defined in the venture DNA. It prevents goalpost shifting and ensures the venture remains anchored to validated customer needs rather than founder intuition.
The founder must produce a hypothesis-versus-evidence mapping document that explicitly compares empirical data against baseline performance thresholds. Every core claim in the venture DNA must be rated as fully validated, partially supported, or invalidated based on hard proof.
Five questions an expert would ask when reviewing your output
Use these to challenge assumptions, pressure-test your logic, and check the quality of this action's output in the context of the parent task and wider venture development.
- 1
Which core assumption in your venture DNA currently rests on the weakest empirical evidence?
- 2
How precisely does your gathered evidence match the quantitative threshold for success you set prior to running these experiments?
- 3
Where have you reinterpreted customer responses to fit your existing venture hypotheses rather than adjusting the hypothesis?
- 4
What evidence demonstrates that the problem you are solving is a top-three operational priority for the prospective buyer?
- 5
How robust is your proof of customer willingness to pay when evaluated against your target price point and unit economics model?